BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Thomas JD, Oliveira R, Sznajder ŁJ, Swanson MS. Myotonic Dystrophy and Developmental Regulation of RNA Processing. Compr Physiol 2018;8:509-53. [PMID: 29687899 DOI: 10.1002/cphy.c170002] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Labat-de-Hoz L, Alonso MA. Formins in Human Disease. Cells 2021;10:2554. [PMID: 34685534 DOI: 10.3390/cells10102554] [Reference Citation Analysis]
2 Raaijmakers RHL, Ripken L, Ausems CRM, Wansink DG. CRISPR/Cas Applications in Myotonic Dystrophy: Expanding Opportunities. Int J Mol Sci 2019;20:E3689. [PMID: 31357652 DOI: 10.3390/ijms20153689] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
3 Chakraborty M, Llamusi B, Artero R. Modeling of Myotonic Dystrophy Cardiac Phenotypes in Drosophila. Front Neurol 2018;9:473. [PMID: 30061855 DOI: 10.3389/fneur.2018.00473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 André LM, van Cruchten RTP, Willemse M, Bezstarosti K, Demmers JAA, van Agtmaal EL, Wansink DG, Wieringa B. Recovery in the Myogenic Program of Congenital Myotonic Dystrophy Myoblasts after Excision of the Expanded (CTG)n Repeat. Int J Mol Sci 2019;20:E5685. [PMID: 31766224 DOI: 10.3390/ijms20225685] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
5 Hinman MN, Richardson JI, Sockol RA, Aronson ED, Stednitz SJ, Murray KN, Berglund JA, Guillemin K. Zebrafish mbnl mutants model physical and molecular phenotypes of myotonic dystrophy. Dis Model Mech 2021;14:dmm045773. [PMID: 34125183 DOI: 10.1242/dmm.045773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Batra R, Nelles DA, Roth DM, Krach F, Nutter CA, Tadokoro T, Thomas JD, Sznajder ŁJ, Blue SM, Gutierrez HL, Liu P, Aigner S, Platoshyn O, Miyanohara A, Marsala M, Swanson MS, Yeo GW. The sustained expression of Cas9 targeting toxic RNAs reverses disease phenotypes in mouse models of myotonic dystrophy type 1. Nat Biomed Eng 2021;5:157-68. [PMID: 32929188 DOI: 10.1038/s41551-020-00607-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 5.0] [Reference Citation Analysis]
7 Sznajder ŁJ, Scotti MM, Shin J, Taylor K, Ivankovic F, Nutter CA, Aslam FN, Subramony SH, Ranum LPW, Swanson MS. Loss of MBNL1 induces RNA misprocessing in the thymus and peripheral blood. Nat Commun 2020;11:2022. [PMID: 32332745 DOI: 10.1038/s41467-020-15962-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
8 Ondono R, Lirio Á, Elvira C, Álvarez-Marimon E, Provenzano C, Cardinali B, Pérez-Alonso M, Perálvarez-Marín A, Borrell JI, Falcone G, Estrada-Tejedor R. Design of novel small molecule base-pair recognizers of toxic CUG RNA transcripts characteristics of DM1. Comput Struct Biotechnol J 2021;19:51-61. [PMID: 33363709 DOI: 10.1016/j.csbj.2020.11.053] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Pruijn IMJ, van Herpen CML, Pegge SAH, van Engen van Grunsven ACH, Ligtenberg MJ, van den Hoogen FJA. Myotonic dystrophy and recurrent pleomorphic adenomas: Case report and association hypothesis. Neuromuscul Disord 2020;30:925-9. [PMID: 33077317 DOI: 10.1016/j.nmd.2020.09.029] [Reference Citation Analysis]
10 Alexander MS, Hightower RM, Reid AL, Bennett AH, Iyer L, Slonim DK, Saha M, Kawahara G, Kunkel LM, Kopin AS, Gupta VA, Kang PB, Draper I. hnRNP L is essential for myogenic differentiation and modulates myotonic dystrophy pathologies. Muscle Nerve 2021;63:928-40. [PMID: 33651408 DOI: 10.1002/mus.27216] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Xing X, Kumari A, Brown J, Brook JD. Disrupting the Molecular Pathway in Myotonic Dystrophy. Int J Mol Sci 2021;22:13225. [PMID: 34948025 DOI: 10.3390/ijms222413225] [Reference Citation Analysis]
12 Subramony SH, Wymer JP, Pinto BS, Wang ET. Sleep disorders in myotonic dystrophies. Muscle & Nerve 2020;62:309-20. [DOI: 10.1002/mus.26866] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
13 Hinkle ER, Wiedner HJ, Black AJ, Giudice J. RNA processing in skeletal muscle biology and disease. Transcription 2019;10:1-20. [PMID: 30556762 DOI: 10.1080/21541264.2018.1558677] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
14 Fernandez-Gomez F, Tran H, Dhaenens CM, Caillet-Boudin ML, Schraen-Maschke S, Blum D, Sablonnière B, Buée-Scherrer V, Buee L, Sergeant N. Myotonic Dystrophy: an RNA Toxic Gain of Function Tauopathy? Adv Exp Med Biol 2019;1184:207-16. [PMID: 32096040 DOI: 10.1007/978-981-32-9358-8_17] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
15 Rossi S, Della Marca G, Ricci M, Perna A, Nicoletti TF, Brunetti V, Meleo E, Calvello M, Petrucci A, Antonini G, Bucci E, Licchelli L, Sancricca C, Massa R, Rastelli E, Botta A, Di Muzio A, Romano S, Garibaldi M, Silvestri G. Prevalence and predictor factors of respiratory impairment in a large cohort of patients with Myotonic Dystrophy type 1 (DM1): A retrospective, cross sectional study. Journal of the Neurological Sciences 2019;399:118-24. [DOI: 10.1016/j.jns.2019.02.012] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
16 Ozimski LL, Sabater-Arcis M, Bargiela A, Artero R. The hallmarks of myotonic dystrophy type 1 muscle dysfunction. Biol Rev Camb Philos Soc 2021;96:716-30. [PMID: 33269537 DOI: 10.1111/brv.12674] [Cited by in Crossref: 4] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]